what's a glp 1 GLP-1 Agonists: Comprehensive Overview GLP-1 Agonists: A Comprehensive Overview

CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the GLP-1 weight-loss medications.

Take this list with you to the grocery store to support your health goals including avoiding side effects and staying nourished.

Ozempic, Wegovy and Mounjaro accounted for nearly $4-billion in sales at retail pharmacies in 2025, according to IQVIA Canada

GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza), and tirzepatide (Mounjaro, Zepbound) have dramatically improved treatment options for Type 2 diabetes and obesity

Online Journal | Justin Plank | January 2025 Background Every year, the United States spends an estimated $173 billion treating obesity-related diseases like diabetes and heart disease, more than the annual budgets of 42 U.S

The FDA has approved three GLP-1 receptor agonist drugs for weight loss